Evidence Hub

BioBehavioral Studies of Cardiovascular Disease

ClinicalTrials.gov · COMPLETED, 2012

272 participants

Abstract

Omega-3 fatty acids are a certain kind of fish fat that has recently been shown to have health benefits. This study will examine the effectiveness of fish oil supplementation for reducing the early signs of heart disease risk and for improving mood, impulsivity, and anger levels.

Conditions: Cardiovascular Diseases, Mood Disorders, Inflammation.

Primary outcome: Circulating Serum Interleukin-6 (IL-6); C-reactive Protein (CRP); Negative Affect; Impulsivity; Aggression; Hostility, Barefoot Score; Trait Anger; Anger Expression; Type A, Total Score; Mean Successive Difference in Inter-beat Intervals Natural Log Transformed Paced Respiration; High Frequency (.12 to .40 Hz) Heart Rate Variability Natural Log Transformed Paced Respiration; Total Power (0 to .40 Hz) Heart Rate Variability Natural Log Transformed Paced Respiration; Mean Successive Difference in Inter-beat Intervals Natural Log Transformed Unpaced Respiration; High Frequency (.12 to .40 Hz) Heart Rate Variability Natural Log Transformed Unpaced Respiration; Total Power (0 to .40 Hz) Heart Rate Variability Natural Log Transformed Unpaced Respiration.

Enrollment: 272 participants.

How strong is the evidence?

Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 272 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free